• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 14, 2023 at 10:22: AM
via Eli Lilly just can't get enough weight loss therapies or acquisitions to bolster its pipeline. The Indianapolis-based company has signed off on a $1.92 billion deal, which covers an upfront payment and potential milestones, for Boston-based Versanis and lead asset bimagrumab.

article source
 




Top Bottom
Back
Quote